1.
Woon DT, Chandrasekar T, Aaron L, Basappa NS, Chi KN, Conter HJ, Gotto G, Hotte SJ, Malone S, Saad F, Shayegan B, Park-Wyllie L, Hamilton RJ. Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces. CUAJ [Internet]. 2018 Jul. 16 [cited 2024 Apr. 23];12(10). Available from: https://cuaj.ca/index.php/journal/article/view/5378